SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-007717
Filing Date
2013-02-06
Accepted
2013-02-06 06:01:03
Documents
5
Period of Report
2013-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-4243_38k.htm 8-K 27391
2 EX-1.1 a13-4243_3ex1d1.htm EX-1.1 247918
3 EX-5.1 a13-4243_3ex5d1.htm EX-5.1 11190
4 EX-99.1 a13-4243_3ex99d1.htm EX-99.1 11419
5 GRAPHIC g42433mmi001.jpg GRAPHIC 3870
  Complete submission text file 0001104659-13-007717.txt   304688
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 13575844
SIC: 2835 In Vitro & In Vivo Diagnostic Substances